References

Association of British Clinical Diabetologists, Renal Association. Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease. 2021. https//tinyurl.com/54z3vavy (accessed 10 October 2023)

Daly L, Byrne G, Keogh B. Contemporary considerations relating to health promotion and older people. Br J Nurs. 2019; 28:(21)1414-1419 https://doi.org/10.12968/bjon.2019.28.21.1414

Davies MJ, D'Alessio DA, Fradkin J Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018; 61:(12)2461-2498 https://doi.org/10.1007/s00125-018-4729-5

Davies MJ, Aroda VR, Collins BS Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2022; 45:(11)2753-2786 https://doi.org/10.2337/dci22-0034

de Boer IH, Khunti K, Sadusky T Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022; 45:(12)3075-3090 https://doi.org/10.2337/dci22-0027

ElSayed NA, Aleppo G, Aroda VR 11. Chronic kidney disease and risk management: Standards of Care in Diabetes—2023. Diabetes Care. 2023a; 46:S191-S202 https://doi.org/10.2337/dc23-S011

ElSayed NA, Aleppo G, Aroda VR Summary of revisions: Standards of Care in Diabetes—2023. Diabetes Care. 2023b; 46:S5-S9 https://doi.org/10.2337/dc23-Srev

EISayed NA, Aleppo G, Aroda VR 5. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes—2023. Diabetes Care. 2023c; 46:S68-S96 https://doi.org/10.2337/dc23-S005

Updated commentary on NICE guidelines (NG136). Hypertension in adults: diagnosis and management including proposals for blood pressure management in patients with chronic kidney disease, with a brief commentary on KDIGO clinical practice guideline for the management of blood pressure in CKD 2021. 2022. https//tinyurl.com/yc5pknt6 (accessed 10 October 2023)

George C, Echouffo-Tcheugui JB, Jaar BG, Okpechi IG, Kengne AP. The need for screening, early diagnosis, and prediction of chronic kidney disease in people with diabetes in low- and middle-income countries—a review of the current literature. BMC Med. 2022; 20:(1) https://doi.org/10.1186/s12916-022-02438-6

Hahr AJ, Molitch ME. Management of diabetes mellitus in patients with CKD: core curriculum 2022. Am J Kidney Dis. 2022; 79:(5)728-736 https://doi.org/10.1053/j.ajkd.2021.05.023

Health Service Executive. Making every contact count: a health behaviour change framework and implementation plan for health professionals in the Irish health service. 2016. https//tinyurl.com/y86day5v (accessed 10 October 2023)

Health Service Executive. The second report of the structured chronic disease management treatment programme in general practice. 2023. https//tinyurl.com/2p8s37y4 (accessed 10 October 2023)

Diabetes and emotional health. A practical guide for healthcare professionals supporting adults with type 1 and type 2 diabetes. 2019. https//tinyurl.com/3u2mtwv8 (accessed 10 October 2023)

UKKA clinical practice guideline: sodium-glucose co-transporter-2 (SGLT-2) inhibition in adults with kidney disease. 2021. https//tinyurl.com/4pjpcwja (accessed 10 October 2023)

UKKA clinical practice guideline: sodium-glucose co-transporter-2 (SGLT-2) inhibition in adults with kidney disease. 2023. https//guidelines.ukkidney.org (accessed 10 October 2023)

Karunathilake SP, Ganegoda GU. Secondary prevention of cardiovascular diseases and application of technology for early diagnosis. Biomed Res Int. 2018; 2018 https://doi.org/10.1155/2018/5767864

Kidney Care UK, National Psychosocial Working Group. Psychosocial health—a manifesto for action. 2033. https//tinyurl.com/yn37rk27 (accessed 10 October 2023)

Kristensen JH, Basit S, Wohlfahrt J, Damholt MB, Boyd HA. Pre-eclampsia and risk of later kidney disease: nationwide cohort study. BMJ. 2019; 365 https://doi.org/10.1136/bmj.l1516

Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in developed countries. Kidney Int Rep. 2020; 5:(3)263-277 https://doi.org/10.1016/j.ekir.2019.12.003

Mayrink J, Souza RT, Feitosa FE Incidence and risk factors for preeclampsia in a cohort of healthy nulliparous pregnant women: a nested case-control study. Sci Rep. 2019; 9:(1) https://doi.org/10.1038/s41598-019-46011-3

Murphy F, Byrne G. Promoting kidney health in cardiovascular disease: part one. British Journal of Cardiac Nursing. 2022a; 17:(10)1-12 https://doi.org/10.12968/bjca.2022.0083

Murphy F, Byrne G. Promoting kidney health in cardiovascular disease: part two. British Journal of Cardiac Nursing. 2022b; 17:(12)1-11 https://doi.org/10.12968/bjca.2022.0111

Murphy F, Byrne G. Promoting kidney health in type 2 diabetes: part 1. Br J Nurs. 2023; 32:(18)874-880 https://doi.org/10.12968/bjon.2023.32.18.874

Naidoo J, Wills J. Foundations for health promotion.Edinburgh: Elsevier Health Sciences; 2016

NHS England. Digital innovations in diabetes. 2023. https//www.england.nhs.uk/diabetes/digital-innovations-to-support-diabetes-outcomes (accessed 11 October 2023)

National Institute for Health and Care Excellence. Chronic kidney disease: assessment and management. NICE guideline NG203. 2021. https//www.nice.org.uk/guidance/ng203

National Institute for Health and Care Excellence. Hypertension in adults: diagnosis and management. NICE guideline NG136. 2022a. https//www.nice.org.uk/guidance/ng136 (accessed 29 July 2023)

National Institute for Health and Care Excellence. Type 2 diabetes in adults: management. NICE guideline NG28. 2022b. https//www.nice.org.uk/guidance/ng28

National Institute for Health and Care Excellence. Type 2 diabetes in adults. Quality standard QS209. 2023a. https//www.nice.org.uk/guidance/qs209 (accessed 10 October 2023)

National Institute for Health and Care Excellence. Diabetes – type 2. Clinical knowledge summary. 2023b. https//cks.nice.org.uk/topics/diabetes-type-2 (accessed 10 October 2023)

Nottingham Area Prescribing Committee. Nottinghamshire health community treatment guideline for the management of type 2 diabetes (T2D) in adults. V5.2. 2022. https//tinyurl.com/2p83pf39 (accessed 10 October 2023)

Owens-Gary MD, Zhang X, Jawanda S, Bullard KM, Allweiss P, Smith BD. The importance of addressing depression and diabetes distress in adults with type 2 diabetes. J Gen Intern Med. 2019; 34:(2)320-324 https://doi.org/10.1007/s11606-018-4705-2

Phillips A. PROTECT NOW: a new resource for diabetes and kidney health. Practice Nursing. 2021; 32:(11)449-450 https://doi.org/10.12968/pnur.2021.32.11.449

Public Health England, NHS England, Health Education England. Making Every Contact Count (MECC): consensus statement. 2016. https//tinyurl.com/u3bwkmht (accessed 10 October 2023)

Rossing P, Caramori ML, Chan JCN Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence. Kidney Int. 2022; 102:(5)990-999 https://doi.org/10.1016/j.kint.2022.06.013

Lifestyle discussions: stress and type 2 diabetes. 2023. https//diabetesonthenet.com/wp-content/uploads/7-8.-Stress-factsheet.pdf (accessed 10 October 2023)

Triozzi JL, Parker Gregg L, Virani SS, Navaneethan SD. Management of type 2 diabetes in chronic kidney disease. BMJ Open Diabetes Res Care. 2021; 9:(1) https://doi.org/10.1136/bmjdrc-2021-002300

Vanholder R, Annemans L, Bello AK Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney. Clin Kidney J. 2021; 14:(7)1719-1730 https://doi.org/10.1093/ckj/sfab070

Vanholder R, Paul T, Conway PT, Daniel Gallego D The European Kidney Health Alliance (EKHA) and the Decade of the KidneyTM. Nephrol Dial Transplant. 2023; 38:(5)1113-1122 https://doi.org/10.1093/ndt/gfac211

Visseren FL, Mach F, Smulders YM ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021; 42:(34)3227-3337 https://doi.org/10.1093/eurheartj/ehab484

Yang Y, Wu N. Gestational diabetes mellitus and preeclampsia: correlation and influencing factors. Front Cardiovasc Med. 2022; https://doi.org/10.3389/fcvm.2022.831297

Diabetes

Promoting kidney health in people with type 2 diabetes: part 2

09 November 2023

Professional

02 November 2023

Volume 32 · Issue 20

ISSN (print): 0966-0461

ISSN (online): 2052-2819

Abstract

The incidence of chronic kidney disease is increasing internationally with many risk factors for chronic kidney disease also being risk factors for type 2 diabetes. Nurses should use primary, secondary and tertiary prevention to minimise the incidence of chronic kidney disease when caring for individuals with type 2 diabetes. This article is the second in a two-part series on the interrelationship between these long-term conditions. Part 1 addressed the significance of using primary prevention to promote kidney health in adults living with type 2 diabetes; part 2 will discuss the use of secondary and tertiary prevention relevant to these long-term conditions.

This article will address the relevance of promoting kidney health using secondary and tertiary preventive measures. It will provide examples to assist nurses and other multidisciplinary team members who work in primary or community care or secondary or hospital care settings to promote kidney health with adults who have type 2 diabetes. It will continue to recognise the triple threat of chronic kidney disease (CKD), type 2 diabetes and cardiovascular disease (CVD) described in part 1 (Murphy and Byrne, 2023).

The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 clinical practice guideline for diabetes management in CKD states that individuals should be managed using a comprehensive approach to maximise both kidney and cardiovascular (CV) outcomes. This should incorporate a combination of lifestyle modification and self-management along with first-line drug therapies depending on patients' clinical characteristics. Additional medications with established kidney and cardiac protection should be incorporated as determined by assessments of remaining risk, and further interventions provided as required to manage additional risk factors (Rossing et al, 2022).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

Limited access to clinical or professional articles
Unlimited access to the latest news, blogs and video content

Or continue by

Signing in with your registered email address

Health promotion

Secondary prevention

Type 2 diabetes

Tertiary prevention

Chronic kidney disease

Cardiovascular disease

Nursing

Education

Screening

Self-management